TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
87.55
+17.00 (24.10%)
Sep 10, 2025, 1:45 PM HKT

HKG:2617 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
--1.180.12
Revenue Growth (YoY)
--852.42%-
Gross Profit
--1.180.12
Selling, General & Admin
74.9947.7439.2249.95
Research & Development
341.34244344.48262.51
Other Operating Expenses
0.030.030.010.02
Operating Expenses
416.36291.77383.7312.48
Operating Income
-416.36-291.77-382.52-312.36
Interest Expense
-0.28-0.2-0.25-0.18
Interest & Investment Income
3.062.1712.166.02
Currency Exchange Gain (Loss)
-0.79-0.43.0127.72
Other Non Operating Income (Expenses)
4.854.9110.1112.57
EBT Excluding Unusual Items
-409.52-285.29-357.49-266.24
Gain (Loss) on Sale of Investments
13.2810.6814.0914.3
Gain (Loss) on Sale of Assets
-0-0-0-0.01
Pretax Income
-396.24-274.61-343.39-251.94
Net Income
-396.24-274.61-343.39-251.94
Net Income to Common
-396.24-274.61-343.39-251.94
Shares Outstanding (Basic)
382382381360
Shares Outstanding (Diluted)
382382381360
Shares Change (YoY)
0.08%0.06%5.83%-
EPS (Basic)
-1.04-0.72-0.90-0.70
EPS (Diluted)
-1.04-0.72-0.90-0.70
Free Cash Flow
--271.96-322.81-238.91
Free Cash Flow Per Share
--0.71-0.85-0.66
Gross Margin
--100.00%100.00%
Operating Margin
---32389.58%-251900.00%
Profit Margin
---29076.54%-203180.65%
Free Cash Flow Margin
---27333.78%-192667.74%
EBITDA
-413.55-288.85-378.87-306.29
D&A For EBITDA
2.812.923.666.07
EBIT
-416.36-291.77-382.52-312.36
Source: S&P Global Market Intelligence. Standard template. Financial Sources.